Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001610618-25-000020
Filing Date
2025-03-06
Accepted
2025-03-06 16:52:49
Documents
5
Effectiveness Date
2025-03-06
Reference 429
333-281523

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM S-8 cdtxs-82025x03x06.htm S-8 63943
2 CALCULATION OF FILING FEE TABLES exhibit1072025-03x06.htm EX-FILING FEES 20143
3 CONSENT OF COOLEY LLP exhibit512025-03x06.htm EX-5.1 11791
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312025-03x06.htm EX-23.1 2113
5 GRAPHIC cooleylogo.jpg GRAPHIC 38052
  Complete submission text file 0001610618-25-000020.txt   150159
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285607 | Film No.: 25716041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)